US approves Chinese drug maker Shanghai Green Valley’s Alzheimer’s therapy for large-scale clinical
A Chinese drug maker has received approval from the Food and Drug Administration to start clinical trials in the US for a breakthrough Alzheimer’s drug as it seeks global validation for the controversial therapy.
